Many randomized controlled trials indicate that vitamin D will reduce falls and fractures. Therefore, the hypothesis in the study by Sanders et al1 in this issue of JAMA, that a single annual 500 000-IU oral dose of cholecalciferol (vitamin D3) would be effective in reducing falls and fractures in older women with 1 or more risk factors for falling was a reasonable one. However, not only was this regimen not effective in lowering risk, it also increased risk of falls and fractures, with the greatest increase occurring during the first 3 months after dosing. An increase in fractures but not falls was reported in another trial in which high-dose ergocalciferol was given intramuscularly each year to men and women 75 years or older.2
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 28
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.